Mode
Text Size
Log in / Sign up

Radiomics and deep learning provide promising tools for precise assessment of adrenal massesAI and radiomics show promise for adrenal tumor diagnosis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that radiomics and deep learning offer promising potential for automated, high-dimensional analysis of adrenal masses.

This systematic review synthesizes the current state of radiomics and deep learning (DL) applications for evaluating adrenal masses, specifically focusing on pheochromocytomas, paragangliomas, adrenal cortical adenomas, and adrenal cortical carcinomas. The scope includes assessing these tools for differentiation, genotype prediction, prognostic evaluation, automated segmentation, feature learning, and end-to-end diagnostic frameworks.

The authors conclude that radiomics and DL are promising tools to enhance the precision of adrenal mass assessment. These methods allow for the extraction of high-dimensional imaging features and enable automated, data-driven analysis. Such capabilities may improve the accuracy of identifying specific tumor types and predicting clinical outcomes.

Several limitations were noted, including technical limitations and barriers to clinical translation. The review notes that these technologies are currently aimed at providing a theoretical foundation for constructing intelligent evaluation systems rather than established clinical protocols. Clinical utility is currently limited by these hurdles in practical implementation.

How this fits prior evidence

This systematic review addresses a gap in the technological assessment of adrenal masses. While prior reports have identified specific clinical presentations, such as paroxysmal hypertension from concurrent primary aldosteronism and micro-pheochromocytoma, or the risk of misdiagnosis when pheochromocytoma mimics allergic vasculitis, this review focuses on the role of radiomics and deep learning to improve diagnostic precision for these conditions.

A systematic review of research on radiomics and deep learning for adrenal mass evaluation suggests these technologies could help doctors better distinguish between different types of adrenal tumors. The review looked at studies using these techniques to differentiate pheochromocytomas, paragangliomas, adrenal cortical adenomas, and adrenal cortical carcinomas. The findings indicate that radiomics and deep learning can extract high-dimensional features from medical images and enable automated analysis, potentially improving diagnostic precision.

However, this is not a clinical trial. The review is a summary of existing research, and the evidence is still early. The authors note that there are technical limitations and barriers to translating these tools into everyday clinical practice. No specific numbers on accuracy or patient outcomes were reported.

For now, these techniques remain promising but not ready for widespread use. Patients with adrenal masses should continue to follow standard diagnostic and treatment recommendations from their doctors. This research provides a theoretical foundation for future development of intelligent adrenal mass evaluation systems.

What this means for you:
AI and radiomics may help diagnose adrenal tumors, but more research is needed before clinical use.

Common questions

What is radiomics?

Radiomics is a method that extracts many features from medical images using computer algorithms. These features can be used to analyze tumors and other abnormalities in detail, potentially helping with diagnosis and treatment planning.

Can AI diagnose adrenal tumors now?

Not yet. The review shows that AI and radiomics are promising tools, but they are not ready for routine clinical use. There are technical limitations and barriers to translation that need to be overcome first.

What types of adrenal masses were studied?

The review included studies on pheochromocytomas, paragangliomas, adrenal cortical adenomas, and adrenal cortical carcinomas. These are different types of tumors that can occur in or near the adrenal glands.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Accurate evaluation of adrenal masses remains a significant challenge in endocrinology and radiology, as differential diagnosis involves a wide spectrum of benign and malignant lesions. Radiomics and deep learning (DL) have emerged as promising tools to enhance the precision of adrenal mass assessment by extracting high-dimensional imaging features and enabling automated, data-driven analysis. This review summarizes the latest advancements in the application of radiomics and DL techniques for adrenal mass evaluation. We systematically describe the workflow of radiomic feature extraction and model development, emphasizing their roles in differentiating key lesions such as pheochromocytomas/paragangliomas (PPGLs), adrenal cortical adenomas, and adrenal cortical carcinomas. Additionally, the utility of these approaches in genotype prediction and prognostic evaluation is highlighted. The review further explores the advantages and potential of DL, particularly convolutional neural networks (CNNs), in automated segmentation, feature learning, and end-to-end diagnostic frameworks. Finally, current challenges including technical limitations, clinical translation barriers, and future research directions are discussed, aiming to provide a theoretical foundation for constructing intelligent and precise adrenal mass evaluation systems.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.